Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
Body unavailable. Use the original source.
Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.